Our Experts 2023
Key Speakers
The Future Medicine Science Match 2023 featured contributions from selected keynote speakers who are significantly shaping the world of cell and gene therapy.
Chairs
The chairs of the Future Medicine Science Match are peers from the scientific community with outstanding expertise in the field of cell and gene therapy. They took on the task of contriving the four sessions that were at the core of the event and engaged suitable speakers for each of their respective sessions.
Speakers
Speakers are the heart and soul of the Future Medicine Science Match event series. Also in 2023 they provided insights into innovations, challenges, and opportunities in numerous dynamic 3-minute short talks,
The actuality of the information on the positions and institutions of the speakers corresponds to the time of the respective event.
Key Speakers
Prof. Christopher Baum
Chairman of the Board of Directors
Berlin Institute of Health at Charité (BIH)
Steffen Braun
VP Sales, Partner
Civey
Dr Johannes Bruns
Secretary-General
German Cancer Society
Franziska Giffey
Mayor of Berlin and Senator for Economic Affairs, Energy and Public Enterprises
Senate Department for Economic Affairs, Energy and Public Enterprises
Dr Holger Krönig
Senior Medical Director Hematology & Oncology
Bristol Myers Squibb
Prof. Annette Künkele-Langer
Senior Attending Physician
Charité - Universitätsmedizin Berlin
Prof. Eicke Latz
Scientific Director
German Rheumatism Research Center Berlin (DRFZ)
Prof. Karl Lauterbach
Federal Minister of Health
Federal Ministry of Health Germany
Dr Olivier Litzka
Partner
Andera Partners
Dr Christine Mißler
Section Manager Life Sciences & Technologies
Berlin Partner for Business and Technology GmbH
Anke Myrrhe
Deputy Editor-in-Chief
Tagesspiegel
Dr Paula Piechotta
Member of the German Bundestag
German Bundestag
Judith Pirscher
State Secretary
Federal Ministry of Education and Research
Dr Patrick Rose
Innovation Manager
SPRIND
Dr Carmen Sanges
EU initiatives Scientific Project Lead
University Hospital Würzburg (UKW)
Dr Herbert Stadler
Managing Director
Cellcopedia GmbH
Thomas Stranzl
Senior Business Unit Director Cell Therapy / Kite
Gilead Sciences GmbH
Prof. Johan Van Eldere
Acting secretary general
EUHA
Martin Völkl
General Manager BeiGene Germany & Austria
BeiGene Germany GmbH
Prof. Hans-Dieter Volk
Director Institute of Medical Immunology
Charite (CVK and BeCAT)
Dr Rainer Wessel
Chief Innovation Officer
Deutsches Krebsforschungszentrum (DKFZ)
Chairs
Prof. Georg Duda
Director
Berlin Institute of Health at Charité - Universitätsmedizin Berlin
Prof. Sarah Hedtrich
Associate Professor
Berlin Institute of Health at Charite
Dr Elisa Kieback
CTO
T-knife
Marina Leonie Moskvina
Senior Manager
UnternehmerTUM
Speakers
Regina Maria Abendroth
Program and Community Manager MAxL
BioM Biotech Cluster Development GmbH
Dr Lina Aires
Co-founder, CEO
immUni Technology
Dr Mazdak Asadian Birjand
Principle Scientist
Sapreme Technologies BV
Daniel Bauersachs
PhD student
Max Delbrück Center
Dr Oshin Behl
Venture Manager
DEEP Institute for Deeptech Innovation
Dr Simon Bornschein
Founder & CEO
coding.bio
Daniela Buchmayr
CEO
Sarcura
Mark Caffrey
CEO
Syntropic Medical
Dr Van Trung Chu
Staff scientist
Max-Delbrück-Center for Molecular Medicine
Petra Dahm
CIO
StellDirVor GmbH
Dr René Fáber
Head of Bioprocess Solutions Division / Member of the Executive Board
Sartorius AG
Dr Martí Farrera-Sal
Postdoctoral scientist
Berlin Institute of Health (BIH)
Dr Emanuel Fleige
CMC Project Manager
Silence Therapeutics
Michael Foehlings
Former Managing Director
TRON GmbH (non-profit)
Dr Daniel Forler
Director Business Development & Licensing
Bayer AG
Prof. Hendrik Fuchs
Universitätsprofessor
Charité – Universitätsmedizin Berlin
Dr Edward Green
CSO
Tcelltech
Dr Bakul Gupta
CEO and Co-founder
Deliver Biosciences
Dr Kilian Guse
CEO
GQ Bio Therapeutics GmbH
Varshith Hakkithimmanahalli Anilkumar
Founder
BlockMMP
Dr Jan Heerma
Partner
Vogel Heerma Waitz
Prof. Regine Heilbronn
Co-Founder and CEO
EpiBlok Therapeutics
Dr Aaron Herrera
Postdoc
BIH @ Charité
Dr Uta Elisabeth Höpken
Senior Group Leader
Max Delbrück Center
Dr Andreas Hüser
Chief Executive Officer
CheckImmune GmbH
Katharina Kauz
Project Manager
TUM Venture Lab Healthcare
Paul Klein
Co-Founder, CFO
ImnoTech GmbH
Dr Lutz Kloke
Founder
Cellbricks GmbH
Dr Sebastian Krammer
Co-Founder
Avelios Medical GmbH
Dr Jan-Philipp Kruse
Senior Director - Open Innovation and BD&L / Lead Co.Lab Berlin
Bayer
Dr Thorsten Lambertus
MD DEEP
ESMT Berlin
Dr Barbara Mayer
PI
University of Munich (LMU)
Dr Guido Moll
Scientist
BIH & Charité
Lasse Riediger
Research Associate
Freie Universität Berlin
Mario Roser
Co-Founder, CTO, Managing Director Development of Patient-Monitoring IoT Devices
Elixion Medical GmbH, Munich
Marius Rummel
Chief Business Officer
Angiolutions GmbH
Gaurav Sadhnani
Doctoral student
BIH - Charité Universitätsmedizin Berlin
Dr Andreas Schmidt
Investor
Springboard Health Angels
Dr Johannes Schmidt
COO
RNATICS GmbH
Dr Massa Shoura
CEO & CSO
Phinomics, Inc.
Inés Simó
Managing Director
Nucleate
Sylvia Stojilkovic
Managing Partner
TechFounders by UnternehmerTUM
Dr Nadine Strempel
Postdoc
DZNE
Emilia Theye
Co-Founder, CEO
clare&me
Dr Stefanie Urlinger
Chief Scientific Officer
Cimeio Therapeutics
Prof. Ludovic Vallier
Principal Investigator
BIH centre for regenerative therapy
Dr Nikki van Teijlingen Bakker
Ventures Associate Health
Plug and Play Tech Center
Dr Johannes von Büren
Medical Director
Wellster Healthtech Group
Prof. Markus Wallwiener
Director
Heidelberg University's Women's Hospital
Dr Anthea Wirges
CEO and Co-Founder
CARTemis Therapeutics GmbH
Dr Karin Wisskirchen
Managing Director
SCG Cell Therapy GmbH
Jannik Woste
CFO & Head of Strategy
HEEROSports GmbH & Unity Innovation Alliance AG
Presenter
Sascha Karlberg
Head of Science Section
Tagesspiegel
Katrin Neumann
Moderation of the day